Impella IQ
Percutaneous ventricular support education for ICU nurses — device family, position signals, the purge system, alarms, complications, and weaning.
This module teaches principles and pattern recognition. Device specifications, flow figures, French sizes, purge concentrations, anticoagulation targets, and positioning limits all vary by device generation, IFU revision, and institution. Values marked Verify are the ones most likely to differ from your practice.
Your institutional protocol and the current manufacturer IFU always take precedence over anything in this app.
Education Modules
Eight modules covering Impella support from physiology to removal.
Device Family
Tap any device to expand. Flows and catheter sizes vary by generation — verify against the current IFU.
Position Signals
Placement signal and motor current — read together, never separately.
The Purge System
What it does, what the pressure means, and what the P-levels do.
The impeller spins inside a motor housing. Without a barrier, blood would enter the motor and clot, destroying the pump. The purge system pushes a dextrose-and-heparin solution outward through the motor housing continuously, creating a pressure barrier that keeps blood out.
- Purge fluid: dextrose (concentration adjusted to tune viscosity) with heparin Concentration is institutional — verify
- Purge pressure: typically ~300–1100 mmHg Verify against IFU
- Purge flow: typically ~2–30 mL/hr Verify against IFU
Tap a pressure state to see causes and nursing actions.
The P-level sets impeller speed, and therefore flow. Tap any level.
Console Alarms
Cause and nursing action for each alarm.
Calculators
Educational tools. Verify all thresholds against institutional protocol.
The strongest single hemodynamic predictor of mortality in cardiogenic shock.
The number behind unexplained suction alarms. An LV Impella cannot pump what the RV does not deliver.
Heparin the patient receives from the purge alone — before any systemic infusion is counted. This dose changes whenever the purge flow rate changes.
On support, pulse pressure is a recovery signal — track the trend.
Clinical Cases
Work through the decision points. Every answer gets a rationale.
Weaning Readiness
A twelve-point checklist. Your progress is saved on this device.
Reduce the P-level one level at a time, observing at each step for a defined interval. Interval is institutional — verify
At each level, ask: is the MAP maintained? Is the pulse pressure widening? Are filling pressures stable? Is CPO maintained? Is lactate stable? Is urine output maintained? Any new suction alarms?
Knowledge Check
Eighteen questions. Rationale on every answer.
Sources & Scope
What this module is based on, and what it deliberately does not do.
- Møller JE, et al. Microaxial Flow Pump or Standard Care in Infarct-Related Cardiogenic Shock (DanGer Shock). N Engl J Med. 2024. — The randomized trial underpinning the AMI-CS indication, and the source of the complication profile emphasized throughout this module.
- O'Neill WW, et al. A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention (PROTECT II). Circulation. 2012;126(14):1717–1727.
- Naidu SS, et al. SCAI SHOCK Stage Classification Expert Consensus Update. J Am Coll Cardiol. 2022;79(9):933–946.
- Abiomed. Impella Instructions for Use and Clinical Reference Manual — device-specific, for each of 2.5, CP, 5.0, 5.5, LD, RP. The authoritative source for all specifications, purge parameters, and positioning values.
- Rihal CS, et al. SCAI/ACC/HFSA/STS Clinical Expert Consensus Statement on the Use of Percutaneous Mechanical Circulatory Support Devices in Cardiovascular Care. J Am Coll Cardiol. 2015;65(19):e7–e26.
- Fincke R, et al. Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock. J Am Coll Cardiol. 2004;44(2):340–348. — The origin of the CPO < 0.6 W threshold.
- Korabathina R, et al. The pulmonary artery pulsatility index identifies severe right ventricular dysfunction in acute inferior myocardial infarction. Catheter Cardiovasc Interv. 2012;80(4):593–600. — The origin of PAPi.
- It does not replace manufacturer training or institutional credentialing on the device.
- It does not give device-specific operating instructions. Console operation, purge setup, cassette changes, and de-airing are taught by your institution against the current IFU.
- It does not provide anticoagulation protocols, ACT targets, or purge concentrations as orders. Those are institutional.
- It does not cover management during cardiac arrest as a protocol — only the physiologic distinction from IABP. Follow your policy.
- It teaches pattern recognition and the reasoning underneath it. That reasoning is durable; the numbers are not.
- IABP IQ — the other mechanical circulatory support device; timing, augmentation, and the physiologic contrast drawn throughout this module.
- Hemodynamic IQ — PA catheter waveforms, CPO, PAPi, and the pressure measurements this module assumes you can obtain and interpret.
- ECMO IQ — VA-ECMO physiology, and the LV loading problem that ECPELLA exists to solve.